首页> 中文期刊>西部中医药 >中药内服联合拔罐治疗强直性脊柱炎36例

中药内服联合拔罐治疗强直性脊柱炎36例

     

摘要

目的:观察中药内服联合拔罐治疗强直性脊柱炎(ankylosing spondylitis,AS)的临床疗效.方法:将72例患者随机分为观察组、对照组各36例,2组均给予常规西医治疗,观察组加用中药内服联合拔罐治疗,观察2组治疗前后各项实验室指标、体征指标的变化情况及临床疗效.结果:血沉(ESR)、C-反应蛋白(CRP)、强直性脊柱炎疾病活动指数(BASDAI)、巴氏强直性脊柱炎功能指数(BASFI)等实验室指标及指地距、枕墙距、胸廓活动度、Schober试验等体征指标,2组治疗前后组内比较,差异有统计学意义(P<0.05),治疗后组间比较,差异也有统计学意义(P<0.05).总有效率观察组为94.44%,对照组为80.56%,2组比较差异有统计学意义(P<0.05).结论:中药内服联合拔罐治疗AS临床疗效显著,可改善各项实验室指标与体征指标,加快患者恢复速度.%Objective: To investigate the clinical efficacy of combined oral administration of herbs with cupping therapy in treating ankylosing spondylitis (AS). Methods: Altogether 72 AS cases were randomly divided into the observation group and the control group, 36 cases each group. Both groups were treated with western medicine, the observation group were further given oral administration of herbs and cupping, the change of lab indexes, body signs indexes and clinical efficacywere observed in both groups before and after treatment. Results: There were statistical differences(P<0.05) in the comparison of lab indexes including ESR,CRP, BASDAI,BASFI and FFD, occipito wall, thoracic ROM, Schober test after treatment within two groups, there were statistical differences between two groups after treating(P<0.05). The total effective rate in the observation group was 94.44%, the control group was 80.56%, there were statistical differences(P<0.05). Conclusion: Oral administration of herbs combined with cupping therapy in treating AS could obtain notable effects, which can improve lab and sign indexes, and accelerate patients' recovery.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号